HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Robert J. Korst Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mahtabifard, A. Articles by Korst, R. J. Search for Related Content PubMed PubMed Citation Articles by Mahtabifard, A. Articles by Korst, R. J. Related Collections Lung - cancer Molecular biology

J Thorac Cardiovasc Surg 2003;126:28-38
© 2003 The American Association for Thoracic Surgery

General thoracic surgery

In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies

^a Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center,, New York, NY, USA
^b Department of Cardiothoracic Surgery,, New York, NY, USA
^c Division of Pulmonary and Critical Care Medicine, New York, NY, USA
^d Department of Genetic Medicine, Weill Medical College of Cornell University, New York, NY, USA

Received for publication August 6, 2002; revisions received September 12, 2002; accepted for publication September 23, 2002.

^* Address for reprints: Robert J. Korst, MD, Department of Cardiothoracic Surgery, M 404, Weill Medical College of Cornell University, 525 East 68th Street, New York, NY 10021, USA
rjk2002{at}med.cornell.edu

OBJECTIVE: Pigment epithelium-derived factor is known to be an inhibitor of angiogenesis. We hypothesized that in vivo gene transfer of pigment epithelium-derived factor may inhibit tumor angiogenesis and growth in syngeneic models of thoracic malignancies.

METHODS: An adenovirus vector encoding the human pigment epithelium-derived factor cDNA (AdPEDF) was used to transduce human lung cancer cells in vitro. Transgene expression was assessed using Western analysis. Three different murine flank tumors (2 lung, 1 colon) were then established in syngeneic mice and treated intratumorally with phosphate-buffered saline, AdPEDF, or an empty vector (AdNull). Endpoints measured included transgene expression, tumor size, and animal survival, as well as microvessel density within the tumor. Additionally, a murine pulmonary metastasis model was established by intravenous injection of a syngeneic colon adenocarcinoma cell line expressing a marker gene (ß-galactosidase). One day later, treatment (phosphate-buffered saline, AdNull, or AdPEDF) was administered intrapleurally. Tumor burden (gross and histologic inspection, lung weight, and ß-galactosidase expression) was then evaluated 13 days after vector dosing, and survival was recorded.

RESULTS: AdPEDF-derived expression of pigment epithelium-derived factor was demonstrated in vitro and in vivo. In syngeneic murine lung cancer flank tumors, intratumoral administration of AdPEDF significantly inhibited tumor growth (P < .01), prolonged mouse survival (P < .01), and decreased microvessel density (P < .01) compared with control groups. In the pulmonary metastasis model, AdPEDF-treated mice exhibited significantly reduced lung lesions, lung weight (P < .0005), ß-galactosidase expression (P < .05), and animal survival was prolonged (P < .05).

CONCLUSION: Gene transfer of pigment epithelium-derived factor suppresses tumor vascularization and growth, while prolonging survival in syngeneic murine models of thoracic malignancies.